Archives for April 6, 2003

← 2003

Side effect concerns recede for Eprex

The latest data on cases of antibody-mediated pure red cell aplasia associated with Johnson & Johnson subsidiary Janssen-Cilag's erythropoietin product Eprex/Erypo (epoetin alfa) have suggested that measures put in place to enhance the safety of the...

Millions poured into research network

The European Commission has earmarked €13 million from the budget of the EU's Sixth Research Framework Programme (FP6) (2002-2006) to promote and facilitate research co-operation with the 13 associated candidate countries for the integration and...